Role of GSK2118436(Dabrafenib) in Landmark PDAC Study: Selleckchem Empowering RAS-GTP Synergistic Research
Selleckchem empowers Nature-published PDAC study: GSK2118436 proves vital for MAPK pathway inhibition and overcoming resistance. HOUSTON, TX, UNITED STATES, April 22, 2026 /EINPresswire.com/ -- GSK2118436 (Dabrafenib), a flagship high-purity compound …